Skip to main content
FT

FireCyte Therapeutics

FireCyte is a neuroscience-based ophthalmology company developing novel multi-target intravitreal injected proteins for retinal disorders. These fusion proteins engage SORT1 and DCC to modulate microglial behavior, offering both anti-inflammatory and neuroprotective effects. The company's approach focuses on direct protection of neurons through targeted neuroscience research.

Traction 1/10
Beverly, United States · HQ
Founded 20224100+ followers
  • Biotechnology
Updated 6 months ago

Funding

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Features

  • FireCyte is a neuroscience-based ophthalmology company developing novel multi-target intravitreal injected proteins for retinal disorders. These fusion proteins engage SORT1 and DCC to modulate microglial behavior, offering both anti-inflammatory and neuroprotective effects. The company's approach focuses on direct protection of neurons through targeted neuroscience research.
This profile is AI-generated and may contain inaccuracies.